Teaching NeuroImage: Hyperglycemia-Induced Occipital Lobe Seizures

Robin Anne Bessemer1, Keng Yeow Tay2, Adrian Budhram2

  • 1From the Department of Clinical Neurological Sciences (R.A.B., A.B.); Department of Medical Imaging (K.Y.T.), Western University, London Health Sciences Centre, London, Ontario, Canada; and Department of Pathology and Laboratory Medicine (A.B.), Western University, London Health Sciences Centre, London, Ontario, Canada. robin.bessemer@lhsc.on.ca.

Neurology
|May 15, 2023
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
460
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
232
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306